Inhibition of FOXO1 with AS1842856 robustly induced apoptosis in LN229, A172, LN18, U118MG, and DBTRG glioblastoma cell lines, highlighting a novel targeted therapy that disrupts circuitry required for cancer progression [75]. The gene discussed is FOXO1; the disease is cancer.